{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:38:29Z","timestamp":1791214709545,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chikungunya virus (CHIKV) is a globally spreading alphavirus against which there is no commercially available vaccine or therapy. Here we use a genome-wide siRNA screen to identify 156 proviral and 41 antiviral host factors affecting CHIKV replication. We analyse the cellular pathways in which human proviral genes are involved and identify druggable targets. Twenty-one small-molecule inhibitors, some of which are FDA approved, targeting six proviral factors or pathways, have high antiviral activity\n                    <jats:italic>in vitro<\/jats:italic>\n                    , with low toxicity. Three identified inhibitors have prophylactic antiviral effects in mouse models of chikungunya infection. Two of them, the calmodulin inhibitor pimozide and the fatty acid synthesis inhibitor TOFA, have a therapeutic effect\n                    <jats:italic>in vivo<\/jats:italic>\n                    when combined. These results demonstrate the value of loss-of-function screening and pathway analysis for the rational identification of small molecules with therapeutic potential and pave the way for the development of new, host-directed, antiviral agents.\n                  <\/jats:p>","DOI":"10.1038\/ncomms11320","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T06:27:25Z","timestamp":1463034445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs"],"prefix":"10.1038","volume":"7","author":[{"given":"Alexander","family":"Karlas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Berre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"Varjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liis","family":"Karo-Astover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friderike","family":"Weege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Sch\u00f6nrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wurzlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Bracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Merits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lecuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,12]]},"reference":[{"key":"BFncomms11320_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMra1406035","volume":"372","author":"SC Weaver","year":"2015","unstructured":"Weaver, S. C. & Lecuit, M. Chikungunya virus and the global spread of a mosquito-borne disease. New Engl. J. Med. 372, 1231\u20131239 (2015).","journal-title":"New Engl. J. Med."},{"key":"BFncomms11320_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1126\/science.aaa3778","volume":"348","author":"E Bekerman","year":"2015","unstructured":"Bekerman, E. & Einav, S. Infectious disease. Combating emerging viral threats. Science 348, 282\u2013283 (2015).","journal-title":"Science"},{"key":"BFncomms11320_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nrd2424","volume":"6","author":"E De Clercq","year":"2007","unstructured":"De Clercq, E. The design of drugs for HIV and HCV. Nat. Rev. Drug Discov. 6, 1001\u20131018 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms11320_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm.3248","volume":"19","author":"TK Scheel","year":"2013","unstructured":"Scheel, T. K. & Rice, C. M. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat. Med. 19, 837\u2013849 (2013).","journal-title":"Nat. Med."},{"key":"BFncomms11320_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198\u2013201 (2010).","journal-title":"Science"},{"key":"BFncomms11320_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.antiviral.2013.03.020","volume":"99","author":"K Lin","year":"2013","unstructured":"Lin, K. & Gallay, P. Curing a viral infection by targeting the host: the example of cyclophilin inhibitors. Antiviral Res. 99, 68\u201377 (2013).","journal-title":"Antiviral Res."},{"key":"BFncomms11320_CR7","doi-asserted-by":"publisher","first-page":"123ra124","DOI":"10.1126\/scitranslmed.3003500","volume":"4","author":"M Garcia","year":"2012","unstructured":"Garcia, M. et al. Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase. Sci. Transl. Med. 4, 123ra124 (2012).","journal-title":"Sci. Transl. Med."},{"key":"BFncomms11320_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673\u2013683 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms11320_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature08760","volume":"463","author":"A Karlas","year":"2010","unstructured":"Karlas, A. et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818\u2013822 (2010).","journal-title":"Nature"},{"key":"BFncomms11320_CR10","doi-asserted-by":"publisher","first-page":"e1003835","DOI":"10.1371\/journal.ppat.1003835","volume":"9","author":"YS Ooi","year":"2013","unstructured":"Ooi, Y. S., Stiles, K. M., Liu, C. Y., Taylor, G. M. & Kielian, M. Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry. PLoS Pathog. 9, e1003835 (2013).","journal-title":"PLoS Pathog."},{"key":"BFncomms11320_CR11","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.celrep.2013.11.028","volume":"5","author":"D Panda","year":"2013","unstructured":"Panda, D. et al. Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of Sindbis virus entry. Cell Rep. 5, 1737\u20131748 (2013).","journal-title":"Cell Rep."},{"key":"BFncomms11320_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.chom.2013.08.007","volume":"14","author":"A Varble","year":"2013","unstructured":"Varble, A. et al. An in vivo RNAi screening approach to identify host determinants of virus replication. Cell Host Microbe 14, 346\u2013356 (2013).","journal-title":"Cell Host Microbe"},{"key":"BFncomms11320_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1152725","volume":"319","author":"AL Brass","year":"2008","unstructured":"Brass, A. L. et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921\u2013926 (2008).","journal-title":"Science"},{"key":"BFncomms11320_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nature08699","volume":"463","author":"R Konig","year":"2010","unstructured":"Konig, R. et al. Human host factors required for influenza virus replication. Nature 463, 813\u2013817 (2010).","journal-title":"Nature"},{"key":"BFncomms11320_CR15","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/gb-2006-7-7-r66","volume":"7","author":"M Boutros","year":"2006","unstructured":"Boutros, M., Bras, L. P. & Huber, W. Analysis of cell-based RNAi screens. Genome Biol. 7, R66 (2006).","journal-title":"Genome Biol."},{"key":"BFncomms11320_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nmeth1089","volume":"4","author":"R Konig","year":"2007","unstructured":"Konig, R. et al. A probability-based approach for the analysis of large-scale RNAi screens. Nat. Methods 4, 847\u2013849 (2007).","journal-title":"Nat. Methods"},{"key":"BFncomms11320_CR17","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1093\/bioinformatics\/btr474","volume":"27","author":"XD Zhang","year":"2011","unstructured":"Zhang, X. D. et al. cSSMD: assessing collective activity for addressing off-target effects in genome-scale RNA interference screens. Bioinformatics 27, 2775\u20132781 (2011).","journal-title":"Bioinformatics"},{"key":"BFncomms11320_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.chom.2009.02.001","volume":"5","author":"AW Tai","year":"2009","unstructured":"Tai, A. W. et al. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5, 298\u2013307 (2009).","journal-title":"Cell Host Microbe"},{"key":"BFncomms11320_CR19","doi-asserted-by":"publisher","first-page":"e1004163","DOI":"10.1371\/journal.ppat.1004163","volume":"10","author":"Q Li","year":"2014","unstructured":"Li, Q. et al. Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle. PLoS Pathog. 10, e1004163 (2014).","journal-title":"PLoS Pathog."},{"key":"BFncomms11320_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nature07967","volume":"458","author":"OM Sessions","year":"2009","unstructured":"Sessions, O. M. et al. Discovery of insect and human dengue virus host factors. Nature 458, 1047\u20131050 (2009).","journal-title":"Nature"},{"key":"BFncomms11320_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature07207","volume":"455","author":"MN Krishnan","year":"2008","unstructured":"Krishnan, M. N. et al. RNA interference screen for human genes associated with West Nile virus infection. Nature 455, 242\u2013245 (2008).","journal-title":"Nature"},{"key":"BFncomms11320_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2008.07.032","volume":"135","author":"R Konig","year":"2008","unstructured":"Konig, R. et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49\u201360 (2008).","journal-title":"Cell"},{"key":"BFncomms11320_CR23","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1073\/pnas.1300708110","volume":"110","author":"G Sivan","year":"2013","unstructured":"Sivan, G. et al. Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Proc. Natl Acad. Sci. USA 110, 3519\u20133524 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11320_CR24","doi-asserted-by":"publisher","first-page":"17345","DOI":"10.1073\/pnas.1010811107","volume":"107","author":"NS Heaton","year":"2010","unstructured":"Heaton, N. S. et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc. Natl Acad. Sci. USA 107, 17345\u201317350 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11320_CR25","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/nbt.1500","volume":"26","author":"J Munger","year":"2008","unstructured":"Munger, J. et al. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26, 1179\u20131186 (2008).","journal-title":"Nat. Biotechnol."},{"key":"BFncomms11320_CR26","doi-asserted-by":"publisher","first-page":"10295","DOI":"10.1128\/JVI.01105-13","volume":"87","author":"M Varjak","year":"2013","unstructured":"Varjak, M. et al. Magnetic fractionation and proteomic dissection of cellular organelles occupied by the late replication complexes of Semliki Forest virus. J. Virol. 87, 10295\u201310312 (2013).","journal-title":"J. Virol."},{"key":"BFncomms11320_CR27","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091\u2013D1097 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFncomms11320_CR28","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis, M. I. et al. Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol. 29, 1046\u20131051 (2011).","journal-title":"Nat. Biotechnol."},{"key":"BFncomms11320_CR29","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton, A. et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100\u2013D1107 (2012).","journal-title":"Nucleic Acids Res."},{"key":"BFncomms11320_CR30","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1371\/journal.ppat.0030089","volume":"3","author":"M Sourisseau","year":"2007","unstructured":"Sourisseau, M. et al. Characterization of reemerging chikungunya virus. PLoS Pathog. 3, e89 (2007).","journal-title":"PLoS Pathog."},{"key":"BFncomms11320_CR31","doi-asserted-by":"publisher","first-page":"e1003914","DOI":"10.1371\/journal.ppat.1003914","volume":"10","author":"A Yasunaga","year":"2014","unstructured":"Yasunaga, A. et al. Genome-wide RNAi screen identifies broadly-acting host factors that inhibit arbovirus infection. PLoS Pathog. 10, e1003914 (2014).","journal-title":"PLoS Pathog."},{"key":"BFncomms11320_CR32","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","volume":"4","author":"T Couderc","year":"2008","unstructured":"Couderc, T. et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signalling are risk factors for severe disease. PLoS Pathog. 4, e29 (2008).","journal-title":"PLoS Pathog."},{"key":"BFncomms11320_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11912-011-0154-3","volume":"13","author":"P Bhargava","year":"2011","unstructured":"Bhargava, P. & Robinson, M. O. Development of second-generation VEGFR tyrosine kinase inhibitors: current status. Curr. Oncol. Rep. 13, 103\u2013111 (2011).","journal-title":"Curr. Oncol. Rep."},{"key":"BFncomms11320_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/1947601912466555","volume":"3","author":"EA Nelson","year":"2012","unstructured":"Nelson, E. A. et al. The STAT5 inhibitor pimozide displays efficacy in models of acute myelogenous leukemia driven by FLT3 mutations. Genes Cancer 3, 503\u2013511 (2012).","journal-title":"Genes Cancer"},{"key":"BFncomms11320_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.exer.2013.05.006","volume":"112","author":"S Kang","year":"2013","unstructured":"Kang, S., Roh, Y. J. & Kim, I. B. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice. Exp. Eye Res. 112, 125\u2013133 (2013).","journal-title":"Exp. Eye Res."},{"key":"BFncomms11320_CR36","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1089\/vbz.2011.0648","volume":"11","author":"SA Ziegler","year":"2011","unstructured":"Ziegler, S. A. et al. In vivo imaging of chikungunya virus in mice and Aedes mosquitoes using a Renilla luciferase clone. Vector Borne Zoonotic Dis. 11, 1471\u20131477 (2011).","journal-title":"Vector Borne Zoonotic Dis."},{"key":"BFncomms11320_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","volume":"178","author":"TE Morrison","year":"2011","unstructured":"Morrison, T. E. et al. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am. J. Pathol. 178, 32\u201340 (2011).","journal-title":"Am. J. Pathol."},{"key":"BFncomms11320_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4049\/jimmunol.1202177","volume":"190","author":"TH Teo","year":"2013","unstructured":"Teo, T. H. et al. A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice. J. Immunol. 190, 259\u2013269 (2013).","journal-title":"J. Immunol."},{"key":"BFncomms11320_CR39","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.ibmb.2005.05.008","volume":"35","author":"DL Vanlandingham","year":"2005","unstructured":"Vanlandingham, D. L. et al. Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes. Insect Biochem. Mol. Biol. 35, 1162\u20131170 (2005).","journal-title":"Insect Biochem. Mol. Biol."},{"key":"BFncomms11320_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1086\/600381","volume":"200","author":"T Couderc","year":"2009","unstructured":"Couderc, T. et al. Prophylaxis and therapy for Chikungunya virus infection. J. Infect. Dis. 200, 516\u2013523 (2009).","journal-title":"J. Infect. Dis."},{"key":"BFncomms11320_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/1743-422X-10-235","volume":"10","author":"S Glasker","year":"2013","unstructured":"Glasker, S. et al. Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout. Virol. J. 10, 235 (2013).","journal-title":"Virol. J."},{"key":"BFncomms11320_CR42","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1073\/pnas.100133697","volume":"97","author":"E Hoffmann","year":"2000","unstructured":"Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl Acad. Sci. USA 97, 6108\u20136113 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11320_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins, A. L. & Groom, C. R. The druggable genome. Nat.Rev.Drug Discov. 1, 727\u2013730 (2002).","journal-title":"Nat.Rev.Drug Discov."},{"key":"BFncomms11320_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"BFncomms11320_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v012.i05","volume":"12","author":"CS Ritz","year":"2005","unstructured":"Ritz, C. S. & Streibig, J. C. Bioassay analysis using R. J. Statist. Software 12, 1\u201322 (2005).","journal-title":"J. Statist. Software"},{"key":"BFncomms11320_CR46","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/jhet.5570380512","volume":"38","author":"MA Ponce","year":"2001","unstructured":"Ponce, M. A. & Erra-Balsells, R. Synthesis and isolation of bromo-beta-carbolines obtained by bromination of beta-carboline alkaloids. J. Heterocyclic Chem. 38, 1087\u20131096 (2001).","journal-title":"J. Heterocyclic Chem."},{"key":"BFncomms11320_CR47","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1248\/cpb.41.1807","volume":"41","author":"H-Y Li","year":"1993","unstructured":"Li, H.-Y., Koike, K. & Ohmoto, T. New alkaloids, picrasidines W, X and Y, from Picrasma quassioides and X-ray crystallographic analysis of picrasidine Q. Chem. Pharm. Bull. 41, 1807\u20131811 (1993).","journal-title":"Chem. Pharm. Bull."},{"key":"BFncomms11320_CR48","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jhet.5570400304","volume":"40","author":"MA Ponce","year":"2003","unstructured":"Ponce, M. A., Tarzi, O. I. & Erra-Balsells, R. Synthesis and isolation of chloro-beta-carbolines obtained by chlorination of beta-carboline alkaloids in solution and in solid state. J. Heterocyclic Chem. 40, 419\u2013426 (2003).","journal-title":"J. Heterocyclic Chem."},{"key":"BFncomms11320_CR49","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/00397910701226228","volume":"37","author":"B Pohl","year":"2007","unstructured":"Pohl, B., Luchterhandt, T. & Bracher, F. Total syntheses of the chlorinated \u03b2\u2010carboline alkaloids bauerine A, B, and C. Synth. Commun. 37, 1273\u20131280 (2007).","journal-title":"Synth. Commun."},{"key":"BFncomms11320_CR50","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nmeth.3180","volume":"11","author":"M Krzywinski","year":"2014","unstructured":"Krzywinski, M. & Altman, N. Points of significance: two-factor designs. Nat. Methods 11, 1187\u20131188 (2014).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms11320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11320","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T06:26:59Z","timestamp":1672813619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms11320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,12]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,1]]}},"alternative-id":["BFncomms11320"],"URL":"https:\/\/doi.org\/10.1038\/ncomms11320","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726353808.793518586","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,12]]},"assertion":[{"value":"6 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11320"}}